Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin
Andrey A. Kolokoltsov(The University of Texas Medical Branch at Galveston), Eric M. Vela(Battelle), Lela Johnson(Texas A&M University), Jennifer Garver(Battelle), Robert A. Davey(Boston University), Shramika Adhikary(The University of Texas Medical Branch at Galveston)
Cited by 46
Related Papers
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
|PubMed Central|2020|528
Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes
|PLoS Pathogens|2010|431
Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus
|PLoS Pathogens|2008|197
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
|Proceedings of the National Academy of Sciences|2021|117
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial
|Science Translational Medicine|2023|49